Skip to main content

Table 2 The outcome comparison between the DHEA FF group versus the control FF group

From: Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial

Paremeters The DHEA FF group The control FF group P-value
  n = 26 n = 35  
Age (years) 36.58 ± 5.95 37.83 ± 4.28 .367
BMI (kg/m2) 22.49 ± 3.10 22.66 ± 2.39 .813
Duration of infertility(years) 7.04 ± 4.99 6.60 ± 5.01 .736
Primary infertility (%) 42.31% 25.71% .270
Secondary infertility (%) 57.69% 74.29%  
AMH (ng/ml) 1.00 ± 0.81 1.19 ± 0.94 .496
FSH (mIU/mL) 11.78 ± 4.92 10.70 ± 2.40 .406
Estradiol (pg/ml) 174.47 ± 122.85 190.45 ± 145.87 .653
Antral follicle count 3.73 ± 1.04 3.51 ± 1.29 .486
BMP-15 (ng/ml) 0.81 ± 0.25 0.35 ± 0.23 .000
GDF-9 (ng/ml) 7.91 ± 3.77 6.82 ± 2.46 .203
  1. Data are presented as mean ± SD (standard deviation) or percentage as appropriate. FF: Follicular fluid. P<.05 was considered as statistically significant.